MAPT and Down syndrome: Tau phosphorylation, however, was unchanged in neurons derived from patients with a PSEN1 mutation [24] and a recent study demonstrated that the increase in tau phosphorylation observed in neurons derived from a patient with Down’s syndrome was unchanged following correction of the APP gene dosage [27].